JP2001513550A5 - - Google Patents

Download PDF

Info

Publication number
JP2001513550A5
JP2001513550A5 JP2000507355A JP2000507355A JP2001513550A5 JP 2001513550 A5 JP2001513550 A5 JP 2001513550A5 JP 2000507355 A JP2000507355 A JP 2000507355A JP 2000507355 A JP2000507355 A JP 2000507355A JP 2001513550 A5 JP2001513550 A5 JP 2001513550A5
Authority
JP
Japan
Prior art keywords
vaginal
suppository
following ingredients
vaginal suppository
combine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000507355A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001513550A (ja
Filing date
Publication date
Priority claimed from DE19737348A external-priority patent/DE19737348C2/de
Application filed filed Critical
Publication of JP2001513550A publication Critical patent/JP2001513550A/ja
Publication of JP2001513550A5 publication Critical patent/JP2001513550A5/ja
Pending legal-status Critical Current

Links

JP2000507355A 1997-08-27 1998-08-27 新規医薬組成物 Pending JP2001513550A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19737348A DE19737348C2 (de) 1997-08-27 1997-08-27 Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
DE19737348.8 1997-08-27
PCT/EP1998/005454 WO1999009964A2 (de) 1997-08-27 1998-08-27 Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektion

Publications (2)

Publication Number Publication Date
JP2001513550A JP2001513550A (ja) 2001-09-04
JP2001513550A5 true JP2001513550A5 (https=) 2009-12-10

Family

ID=7840348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000507355A Pending JP2001513550A (ja) 1997-08-27 1998-08-27 新規医薬組成物

Country Status (7)

Country Link
US (1) US6537970B1 (https=)
EP (1) EP1009414B1 (https=)
JP (1) JP2001513550A (https=)
AT (1) ATE308328T1 (https=)
AU (1) AU9534398A (https=)
DE (2) DE19737348C2 (https=)
WO (1) WO1999009964A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709482B2 (en) 2004-08-05 2014-04-29 Ferring B.V. Stabilised prostaglandin composition

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
DE60204897T2 (de) * 2001-08-28 2006-05-11 Pharmacia Corp. Kristalline freie base von clindamycin
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
ATE400270T1 (de) * 2002-12-18 2008-07-15 Ferrer Int Pharmazeutische zusammensetzungen mit sertaconazol für vaginale verwendung
MXPA05008571A (es) * 2005-08-12 2007-02-12 Leopoldo Espinosa Abdala Formulaciones farmaceuticas solidas, semisolidas, en suspension, en solucion, en emulsion o en jarabe conteniendo clindamicina y uno o mas de los miembros de la familia de los azoles.
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US8603513B2 (en) * 2007-06-28 2013-12-10 The Procter & Gamble Company Article comprising calcium for reducing the production of TSST-1
EP2130531A1 (en) * 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginal suppository comprising lactic acid
US20100285095A1 (en) * 2009-05-05 2010-11-11 Kimberly Ann Nemeth Hygiene Article Having Calcium Sugar Acid Salt
US20100285096A1 (en) * 2009-05-05 2010-11-11 Fancheng Wang Hygiene Article Having Calcium Sugar Phosphate
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
WO2011101826A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, terbinafine and dexamethasone, and a process to make it
WO2012049544A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a hydrocortisone acetate as a corticosteroid, and clotrimazole as an antifungal agent, and a process to make it
WO2012049542A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, mometasone as a corticosteroid and clotrimazol as antifungal agent, and a process to make it
CN103830198B (zh) * 2012-11-28 2016-05-18 南京亿华药业有限公司 一种克霉唑阴道片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318853A (en) * 1980-01-31 1982-03-09 The Upjohn Company 9β,11β-Epoxy-5β-corticoids
US5160737A (en) 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709482B2 (en) 2004-08-05 2014-04-29 Ferring B.V. Stabilised prostaglandin composition

Similar Documents

Publication Publication Date Title
JP2001513550A5 (https=)
JP2952505B2 (ja) 抗ウイルス性薬剤
JPS61106511A (ja) 抗真菌性医薬組成物
US20200054552A1 (en) Medicament for the treatment of viral skin and tumour diseases
FI89065C (fi) Foerfarande foer framstaellning av en ny siklosporin kristallform
US12357655B2 (en) Polyglutamic acid compositions and methods of using
RU2012127436A (ru) Фармацевтическая композиция для местного применения, способ местного вагинального введения и способ профилактики инфицирования вич с ее помощью, презерватив ее содержащий, лекарственное средство (варианты) и способ профилактики заболеваний, передающихся половым путем
CZ272995A3 (en) Pharmaceutical preparation for oral administration
JPH09165344A (ja) 膣用固形医薬品組成物
EP0308564B1 (fr) Composition inhibitrice ou destructrice d'au moins un être vivant unicellulaire renfermant un fluorure d'ammononium quaternaire et procédé de préparation de ce sel
JPH10503194A (ja) 多くの異なる活性成分を含有する医薬組成物、主として腟座薬
LT4441B (lt) Antigliukokortikoidinis vaistinis preparatas
BE1007158A3 (fr) Composition pharmaceutique a base d'une imidazolylcarbazolone destinee a l'adminstration rectale.
WO2002004012A1 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
RU2257197C1 (ru) Вагинальные суппозитории, обладающие контрацептивным действием
CZ20021433A3 (cs) Proléčivo na bázi 6-methoxy-2-naftyloctové kyseliny
JPWO2021159021A5 (https=)
CN102525883A (zh) 一种伏立康唑栓剂及其制备方法和用途
JPH09176014A (ja) 抗真菌性外用組成物
JP5743375B2 (ja) カンジダ症予防又は治療剤
JP2516477B2 (ja) 皮膚の血行不良に起因する疾患の治療剤
WO2021099901A1 (en) Stable topical pharmaceutical composition
RU2205011C1 (ru) Фармацевтическая композиция с антибактериальной активностью
JPWO2023118557A5 (https=)
EP1641470A1 (en) Vaginal compositions for treating pelvic tissue infections and traumas